YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Ingenuity, Affymetrix Co-Promote Tools


By Bio-IT World Staff

April 8, 2013 | Ingenuity Systems and Affymetrix have announced that they will co-promote Ingenuity iReport with Affymetrix expression microarray products, coupling statistical analysis and biological interpretation workflow with a gene expression platform.

Ingenuity iReport is an interactive web-based report that leverages the Ingenuity Knowledge Base of biological and chemical findings from the peer reviewed literature and databases. When used with Affymetrix microarrays, the pair will give researchers a “sample to insight” continuous workflow, allowing for rapid, confident interpretation of results without the need for bioinformatics experience or support, the two companies believe.

“We are excited to partner with Ingenuity Systems to provide our array users with access to the intuitive biological and statistical analysis platform offered by iReport,” said Kevin Cannon, SVP of the Expression Business Unit at Affymetrix in a statement. “Bundling together our robust expression microarrays with the iReport platform will provide Affymetrix’ customers with a simple and accurate tool to convert data into biologically relevant results.”

Adrian Grimes, from the Department of Pediatrics at the University of Wisconsin, commented: "By leveraging Ingenuity iReport with Affymetrix gene expression arrays for our study on a mouse model of Familial Hypertrophic Cardiomyopathy, we accelerated our data interpretation several-fold compared to using other analysis tools. Their rapid and effectively-blind analysis provided an unbiased validation of our data. Additionally, iReport allowed us to identify and explore genes of interest found with Affymetrix gene chips, yet not identified by other analysis tools.” Ingenuity

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.